EUVIMEDEUVIMED entdecken
Editorial

Bridging the Gap in Hydroxychloroquine Monitoring for SLE : Evidence, Limitations, and Future Directions

Tang-Kai Cheng iD, James Cheng-Chung Wei iD

International Journal of Rheumatic Diseases · 2026-07 · 29 (7)

DOI: 10.1111/1756-185x.70759 ↗

Kurz gefasst

Editorial in der Zeitschrift International Journal of Rheumatic Diseases, online erschienen am 05.07.2026. Verfasst von Tang-Kai Cheng und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology, Chung Shan Medical University Hospital, Taichung, Taiwan. Die Arbeit nennt 9 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of Rheumatology, Chung Shan Medical University Hospital, Taichung, Taiwan.
  • Department of Allergy, Immunology & Rheumatology, Chung Shan Medical University Hospital, Taichung, Taiwan.
  • Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan.
  • Graduate Institute of Integrated Medicine, China Medical University, Taichung, Taiwan.

ORCID-Profile: Tang-Kai Cheng, James Cheng-Chung Wei

Zitieren

APA

Cheng, T. K., & Wei, J. C. (2026). Bridging the Gap in Hydroxychloroquine Monitoring for SLE : Evidence, Limitations, and Future Directions. International Journal of Rheumatic Diseases, 29(7). https://doi.org/10.1111/1756-185x.70759

Vancouver

Cheng TK, Wei JC. Bridging the Gap in Hydroxychloroquine Monitoring for SLE : Evidence, Limitations, and Future Directions. International Journal of Rheumatic Diseases. 2026;29(7). doi:10.1111/1756-185x.70759

BibTeX
@article{Cheng2026,
  author = {Cheng, Tang-Kai and Wei, James Cheng-Chung},
  title = {Bridging the Gap in Hydroxychloroquine Monitoring for SLE : Evidence, Limitations, and Future Directions},
  journal = {International Journal of Rheumatic Diseases},
  year = {2026},
  volume = {29},
  number = {7},
  doi = {10.1111/1756-185x.70759}
}
Kostenlos starten →